Hypertrophic Cardiomyopathy After a Single Dose of Dexamethasone in a Preterm Infant.
Dexamethasone is widely used in preterm infants with severe pulmonary disease. Hypertrophic cardiomyopathy (HCM) is a transient side effect observed after multiple doses of dexamethasone. We report a preterm infant with myocardial hypertrophy after a single dose of dexamethasone (0.5 mg/kg) used to treat laryngeal edema secondary to prolonged intubation. A benign course was observed without left ventricular outflow tract obstruction and with recovery within 4 weeks. Myocardial effects of dexamethasone may be independent of dose and duration of treatment. The risk/benefit ratio must be carefully considered before using even a single dose of dexamethasone in preterm infants.
['Kale|Yusuf|Y|', 'Aydemir|Ozge|O|', 'Ceylan|Ozben|O|', 'Bas|Ahmet Yagmur|AY|', 'Demirel|Nihal|N|']
D002312:Cardiomyopathy, Hypertrophic D003907:Dexamethasone D005260:Female D005938:Glucocorticoids D006801:Humans D007223:Infant D007231:Infant, Newborn D007234:Infant, Premature D008171:Lung Diseases
hypertrophic cardiomyopathy dexamethasone preterm infant neonate